Introduction Glioblastoma is the most malignant brain tumor in adults and is associated with poor sur- vival despite multimodal treatments. Glioma stem-like cells (GSCs) are cells functionally defined by their self-renewal potential and the ability to reconstitute the original tumor upon orthotopic implantation. They have been postulated to be the culprit of glioma chemo- and radio-resistance ultimately leading to relapse. Understanding the molecular circuits govern- ing the GSC compartment is essential. SOX2, a critical transcription regulator of embryonic and neural stem cell function, is deregulated in GSCs however; the precise molecular path- ways regulated by this gene in GSCs remain poorly understood. Results We pe...
Sox2 is a key transcription factor that maintains the proliferation of neuroglial stem cells and in...
Medulloblastomas and glioblastomas are devastating tumors that respond poorly to treatment. These tu...
We undertook this study to understand how the transcription factor Sox2 contributes to the malignant...
<div><p>Introduction</p><p>Glioblastoma is the most malignant brain tumor in adults and is associate...
INTRODUCTION:Glioblastoma is the most malignant brain tumor in adults and is associated with poor su...
AbstractThe high-mobility group–box transcription factor sex-determining region Y–box 2 (Sox2) is es...
SOX genes are developmental regulators with functions in the instruction of cell fate and maintenanc...
We undertook this study to understand how the transcription factor Sox2 contributes to the malignant...
The high-mobility group–box transcription factor sex-determining region Y–box 2 (Sox2) is essential ...
Glioblastoma (GBM) is the most common, most aggressive and deadliest brain tumor. Recently, remarkab...
Glioblastoma, the most aggressive cerebral tumor, is invariably lethal. Glioblastoma cells express s...
Glioblastoma (GBM) is the most common malignant primary brain tumour in adults, with a median surviv...
Abstract Background SOX2 is a key gene implicated in maintaining the stemness of embryonic and adult...
Glioblastoma (GBM) continues to be the most devastating primary brain malignancy. Despite significan...
<div><p>Medulloblastomas and glioblastomas are devastating tumors that respond poorly to treatment. ...
Sox2 is a key transcription factor that maintains the proliferation of neuroglial stem cells and in...
Medulloblastomas and glioblastomas are devastating tumors that respond poorly to treatment. These tu...
We undertook this study to understand how the transcription factor Sox2 contributes to the malignant...
<div><p>Introduction</p><p>Glioblastoma is the most malignant brain tumor in adults and is associate...
INTRODUCTION:Glioblastoma is the most malignant brain tumor in adults and is associated with poor su...
AbstractThe high-mobility group–box transcription factor sex-determining region Y–box 2 (Sox2) is es...
SOX genes are developmental regulators with functions in the instruction of cell fate and maintenanc...
We undertook this study to understand how the transcription factor Sox2 contributes to the malignant...
The high-mobility group–box transcription factor sex-determining region Y–box 2 (Sox2) is essential ...
Glioblastoma (GBM) is the most common, most aggressive and deadliest brain tumor. Recently, remarkab...
Glioblastoma, the most aggressive cerebral tumor, is invariably lethal. Glioblastoma cells express s...
Glioblastoma (GBM) is the most common malignant primary brain tumour in adults, with a median surviv...
Abstract Background SOX2 is a key gene implicated in maintaining the stemness of embryonic and adult...
Glioblastoma (GBM) continues to be the most devastating primary brain malignancy. Despite significan...
<div><p>Medulloblastomas and glioblastomas are devastating tumors that respond poorly to treatment. ...
Sox2 is a key transcription factor that maintains the proliferation of neuroglial stem cells and in...
Medulloblastomas and glioblastomas are devastating tumors that respond poorly to treatment. These tu...
We undertook this study to understand how the transcription factor Sox2 contributes to the malignant...